354 related articles for article (PubMed ID: 28219397)
1. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
[TBL] [Abstract][Full Text] [Related]
2. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
[TBL] [Abstract][Full Text] [Related]
3. Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy.
Sheriffs IN; Rampling D; Smith VV
J Clin Pathol; 2001 Jul; 54(7):517-20. PubMed ID: 11429422
[TBL] [Abstract][Full Text] [Related]
4. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
5. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Bönnemann CG; Finkel RS
Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
[TBL] [Abstract][Full Text] [Related]
6. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
7. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
[TBL] [Abstract][Full Text] [Related]
8. Increased dysferlin expression in Duchenne muscular dystrophy.
Vontzalidis A; Terzis G; Manta P
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
[TBL] [Abstract][Full Text] [Related]
9. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
[TBL] [Abstract][Full Text] [Related]
10. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.
Assereto S; Mastrototaro M; Stringara S; Gazzerro E; Broda P; Nicchia GP; Svelto M; Bruno C; Nigro V; Lisanti MP; Frigeri A; Minetti C
Cell Cycle; 2008 Jul; 7(14):2199-207. PubMed ID: 18641458
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection analysis of muscular dystrophies in Mexico.
Gómez-Díaz B; Rosas-Vargas H; Roque-Ramírez B; Meza-Espinoza P; Ruano-Calderón LA; Fernández-Valverde F; Escalante-Bautista D; Escobar-Cedillo RE; Sánchez-Chapul L; Vargas-Cañas S; López-Hernández LB; Bahena-Martínez E; Luna-Angulo AB; Canto P; Coral-Vázquez RM
Muscle Nerve; 2012 Mar; 45(3):338-45. PubMed ID: 22334167
[TBL] [Abstract][Full Text] [Related]
13. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
[TBL] [Abstract][Full Text] [Related]
14. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy.
Kawajiri M; Mitsui T; Kawai H; Kobunai T; Tsuchihashi T; Saito S
J Neuropathol Exp Neurol; 1996 Aug; 55(8):896-903. PubMed ID: 8759779
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
Di Blasi C; Morandi L; Barresi R; Blasevich F; Cornelio F; Mora M
Acta Neuropathol; 1996 Oct; 92(4):369-77. PubMed ID: 8891069
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy.
Dai Y; Liang S; Dong X; Zhao Y; Ren H; Guan Y; Yin H; Li C; Chen L; Cui L; Banerjee S
J Cell Mol Med; 2019 Feb; 23(2):811-818. PubMed ID: 30450679
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
Hoshino S; Ohkoshi N; Watanabe M; Shoji S
Neuromuscul Disord; 2000 Aug; 10(6):425-9. PubMed ID: 10899449
[TBL] [Abstract][Full Text] [Related]
19. Analysis of calpain-3 protein in muscle biopsies of different muscular dystrophies from India.
Renjini R; Gayathri N; Nalini A; Srinivas Bharath MM
Indian J Med Res; 2012 Jun; 135(6):878-86. PubMed ID: 22825607
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
Jones KJ; Kim SS; North KN
J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]